Vendor review
Shanghai OuDaXin New Material Technology Center reviews
Shanghai OuDaXin New Material Technology Center reviews from 55 independent lab tests (Tirzepatide, Retatrutide and Tesamorelin): grade A, purity and fill accuracy. Is Shanghai OuDaXin New Material Technology Center legit? See what its vials showed.
What the lab tests show
55 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Apr 23, 2026 | Tirzepatide | 99.9 % | 28.5 mg of 30 mg (-5 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 19 mg of 20 mg (-5 %) | Pass | View |
| Feb 26, 2026 | Tesamorelin | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 20, 2026 | Ipamorelin | 99.67 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Feb 20, 2026 | CJC-1295 | 99.7 % | 4.7 mg of 5 mg (-6 %) | Pass | View |
| Feb 10, 2026 | Tirzepatide | 99.8 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Feb 10, 2026 | Retatrutide | 99.7 % | 16.6 mg of 15 mg (11 %) | Pass | View |
| Feb 4, 2026 | Ipamorelin | 99.7 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Feb 4, 2026 | Retatrutide | 99.5 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.6 % | 5.22 mg of 5 mg (4 %) | Pass | View |
| Jan 19, 2026 | Tesamorelin | 99.95 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.9 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.17 % | 13 mg of 10 mg (30 %) | Pass | View |
| Jan 9, 2026 | Tirzepatide | 99.95 % | 28.6 mg of 30 mg (-5 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.8 % | 11.5 mg of 10 mg (15 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.8 % | 34.7 mg of 30 mg (16 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.7 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.77 % | 5.18 mg of 5 mg (4 %) | Pass | View |
| Jan 1, 2026 | Retatrutide | 99.5 % | 4.9 mg of 5 mg (-2 %) | Pass | View |
| Jan 1, 2026 | BPC-157 | 99.8 % | 4.6 mg of 5 mg (-8 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 30 mg | Fail | View | |
| Dec 29, 2025 | Tirzepatide | 99.95 % | 19 mg of 20 mg (-5 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.8 % | 51 mg of 60 mg (-15 %) | Pass | View |
| Dec 29, 2025 | Tesamorelin | 10 mg | Fail | View | |
| Dec 22, 2025 | Retatrutide | 99.79 % | 27.3 mg of 30 mg (-9 %) | Pass | View |
| Dec 18, 2025 | Tirzepatide | 30 mg | Fail | View | |
| Dec 17, 2025 | BPC-157 | 99.95 % | 5.7 mg of 10 mg (-43 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 30 mg | Fail | View | |
| Dec 10, 2025 | BPC-157 | 99.1 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| Dec 6, 2025 | Retatrutide | 30 mg | Fail | View | |
| Dec 6, 2025 | Tesamorelin | 99.95 % | 2.33 mg of 5 mg (-53 %) | Pass | View |
| Dec 6, 2025 | Tesamorelin | 10 mg | Fail | View | |
| Dec 6, 2025 | CJC-1295 | 83.5 % | 9.3 mg of 10 mg (-7 %) | Pass | View |
| Nov 25, 2025 | Retatrutide | 30 mg | Fail | View | |
| Nov 25, 2025 | Tirzepatide | 30 mg | Fail | View | |
| Nov 25, 2025 | Tirzepatide | 30 mg | Fail | View | |
| Nov 25, 2025 | Retatrutide | 10 mg | Fail | View | |
| Nov 23, 2025 | Ipamorelin | 99.8 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Nov 4, 2025 | Ipamorelin | 99.17 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Nov 4, 2025 | CJC-1295 | 99.95 % | 5.09 mg of 5 mg (2 %) | Pass | View |
| Oct 9, 2025 | Tesamorelin | 99.85 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Oct 9, 2025 | Tesamorelin | 99.77 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Sep 30, 2025 | Tirzepatide | 99.95 % | 33 mg of 30 mg (10 %) | Pass | View |
| Sep 30, 2025 | Tirzepatide | 99.87 % | 4.85 mg of 5 mg (-3 %) | Pass | View |
| Aug 12, 2025 | Tirzepatide | 99.942 % | 9.73 mg of 10 mg (-3 %) | Pass | View |
| Aug 11, 2025 | Retatrutide | 99.92 % | 19.9 mg of 20 mg (-1 %) | Pass | View |
| Aug 11, 2025 | Tesamorelin | 99.86 % | 5.09 mg of 5 mg (2 %) | Pass | View |
| Aug 5, 2025 | Tirzepatide | 99.82 % | 9.72 mg of 10 mg (-3 %) | Pass | View |
| Jun 20, 2025 | Tirzepatide | 99.77 % | 19.7 mg of 20 mg (-2 %) | Pass | View |
| Jun 20, 2025 | Tirzepatide | 99.89 % | 28.2 mg of 30 mg (-6 %) | Pass | View |
| Jun 20, 2025 | Tirzepatide | 99.74 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
| Jun 13, 2025 | Tirzepatide | 99.8 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Jun 11, 2025 | Tirzepatide | 99.64 % | 16.8 mg of 20 mg (-16 %) | Pass | View |
| Jun 11, 2025 | Tirzepatide | 99.84 % | 14.7 mg of 15 mg (-2 %) | Pass | View |
| Jun 3, 2025 | Tirzepatide | 99.79 % | 34.9 mg of 40 mg (-13 %) | Pass | View |
What Shanghai OuDaXin New Material Technology Center sells
No current listings on record.
About Shanghai OuDaXin New Material Technology Center
Finnrick has tested 55 samples from Shanghai OuDaXin New Material Technology Center across 6 products.